خط مشی دسترسیدرباره ما
ثبت نامثبت نام
راهنماراهنما
فارسی
ورودورود
صفحه اصلیصفحه اصلی
جستجوی مدارک
تمام متن
منابع دیجیتالی
رکورد قبلیرکورد بعدی
library name : انستیتو تغذیه دانشگاه علوم پزشکی شهید بهشتی
Material Type : Latin Articles
Language of Document : English
Record Number : 62067
Doc. No : 728A
Main Entry : ESMAEILI M
Title & Author : ORAL VITAMIN E AND RENAL ANEMIA IN CHRONIC HEMODIALYSIS CHILDREN (POSTER PRESENTATIONS: P126) [Article]
Title : IRANIAN JOURNAL OF KIDNEY DISEASES (IJKD)
Volume Number : , Vol.3 ؛ No.SUPPLEMENT 1
Date : , (2009)
page : : 19 - 19
Abstract : Introduction. Renal anemia is one of the most frequently observed complications in patients undergoing chronic hemodialysis )HD(. Reduced red blood cell survival due to oxidative damage is one of the causes of anemia in these patients. Vitamin E )alpha ع tocopherol( is a natural biological antioxidant, which protects red cells from the effects of reactive oxygen metabolites and could be useful as a collateral therapy for anemia in HD patients. The aim of the present study was to investigate the potential beneficial effect of anti-oxidant vitamin E supplementation )oral( on renal anemia and to find out whether this improvement mechanism is attributable to the enhanced hematopoietic function or to the prolonged RBC life. Methods. This clinical trial study included )8 cases with mean age of 14 ▒آ 2.9 years and 7 controls with mean age of 14 ▒آ 2.7 years( stable children on chronic hemodialysis, at hemodialysis center in Sheikh children hospital, Mashhad. At the time of entry, there was no evidence of iron deficiency or history of blood transfusion. All of the children )case and control( received subcutaneous erythropoietin )EPO( with the dose of 120 ▒آ 80 u/kg/ BW/week, folic acid with the dose of 1 mg/day, and iron with the dose of 1 to 2 mg/kg/day. Oral vitamin E )200 u/day( for 3 months was only prescribed to the cases. Laboratory parameters determined at the beginning of the study were: iron, ferritin, transferrin, total iron binding capacity, hemoglobin )Hb(, hematocrit, reticulocyte count, and peripheral blood smear. Hb and HCT were checked every month during the study and the results were compared with those obtained earlier.Results. Prescription of oral vitamin E for 3 months resulted in significantly higher levels of Hb and HCT in the cases compared to those in the controls )11.4 ▒آ 1.7 vs. 10.1 ▒آ 1.9 Hb and 35.3▒آ 5 vs. 31.3 ▒آ 6 Htc, P < 0.05(. Conclusion. Antioxidant vitamin E supplementation improves renal anemia by decrease of oxidative stress and RBC life span in hemodialysis patients.
Descriptor : IBUPROFEN
Descriptor : VERY LOW BIRTH WEIGHT
Descriptor : PATENT DUCTUS ARTERIOSUS
Added Entry : GHANE F
 
 
 
(در صورت عدم وضوح تصویر اینجا را کلیک نمایید)